Literature DB >> 28275173

Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract.

Kenrie P Y Hui1,2, Louisa L Y Chan1,2, Denise I T Kuok1, Chris K P Mok1,3, Zi-Feng Yang4, Run-Feng Li4, Geraldine S M Luk5, Elaine F Lee5, Jimmy C C Lai1,3, Hui-Ling Yen1, Huachen Zhu1, Yi Guan1, John M Nicholls6, J S Malik Peiris1, Michael C W Chan7.   

Abstract

Since their first isolation in 2013, influenza A/H5N6 viruses have spread amongst poultry across multiple provinces in China and to Laos, Vietnam and Myanmar. So far, there have been 14 human H5N6 infections with 10 fatalities.We investigated the tropism, replication competence and cytokine induction of one human and two avian H5N6 isolates in ex vivo and in vitro cultures derived from the human respiratory tract. Virus tropism and replication were studied in ex vivo cultures of human nasopharynx, bronchus and lung. Induction of cytokines and chemokines was measured in vitro in virus-infected primary human alveolar epithelial cells.Human H5N6 virus replicated more efficiently than highly pathogenic avian influenza (HPAI) H5N1 virus and as efficiently as H1N1pdm in ex vivo human bronchus and lung and was also able to replicate in ex vivo cultures of human nasopharynx. Avian H5N6 viruses replicated less efficiently than H1N1pdm in human bronchial tissues and to similar titres as HPAI H5N1 in the lung. While the human H5N6 virus had affinity for avian-like receptors, the two avian isolates had binding affinity for both avian- and human-like receptors. All three H5N6 viruses were less potent inducers of pro-inflammatory cytokines compared with H5N1 virus.Human H5N6 virus appears better adapted to infect the human airways than H5N1 virus and may pose a significant public health threat.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28275173     DOI: 10.1183/13993003.01710-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

1.  Efficacy of Neuraminidase Inhibitors against H5N6 Highly Pathogenic Avian Influenza Virus in a Nonhuman Primate Model.

Authors:  Cong Thanh Nguyen; Saori Suzuki; Yasushi Itoh; Hirohito Ishigaki; Misako Nakayama; Kaori Hayashi; Keita Matsuno; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida; Kazumasa Ogasawara
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

2.  SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo.

Authors:  Kenrie P Y Hui; John C W Ho; Man-Chun Cheung; Ka-Chun Ng; Rachel H H Ching; Ka-Ling Lai; Tonia Tong Kam; Haogao Gu; Ko-Yung Sit; Michael K Y Hsin; Timmy W K Au; Leo L M Poon; Malik Peiris; John M Nicholls; Michael C W Chan
Journal:  Nature       Date:  2022-02-01       Impact factor: 49.962

3.  Human Clade 2.3.4.4 A/H5N6 Influenza Virus Lacks Mammalian Adaptation Markers and Does Not Transmit via the Airborne Route between Ferrets.

Authors:  Sander Herfst; Chris K P Mok; Judith M A van den Brand; Stefan van der Vliet; Miruna E Rosu; Monique I Spronken; Zifeng Yang; Dennis de Meulder; Pascal Lexmond; Theo M Bestebroer; J S Malik Peiris; Ron A M Fouchier; Mathilde Richard
Journal:  mSphere       Date:  2018-01-03       Impact factor: 4.389

4.  Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.

Authors:  Kenrie P Y Hui; Man-Chun Cheung; Ranawaka A P M Perera; Ka-Chun Ng; Christine H T Bui; John C W Ho; Mandy M T Ng; Denise I T Kuok; Kendrick C Shih; Sai-Wah Tsao; Leo L M Poon; Malik Peiris; John M Nicholls; Michael C W Chan
Journal:  Lancet Respir Med       Date:  2020-05-07       Impact factor: 30.700

Review 5.  COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives.

Authors:  Jiumeng Sun; Wan-Ting He; Lifang Wang; Alexander Lai; Xiang Ji; Xiaofeng Zhai; Gairu Li; Marc A Suchard; Jin Tian; Jiyong Zhou; Michael Veit; Shuo Su
Journal:  Trends Mol Med       Date:  2020-03-21       Impact factor: 11.951

6.  Development of a duplex TaqMan real-time RT-PCR assay for simultaneous detection of newly emerged H5N6 influenza viruses.

Authors:  Lin Liu; Ying Zhang; Pengfei Cui; Congcong Wang; Xianying Zeng; Guohua Deng; Xiurong Wang
Journal:  Virol J       Date:  2019-10-22       Impact factor: 4.099

Review 7.  Alternative Experimental Models for Studying Influenza Proteins, Host-Virus Interactions and Anti-Influenza Drugs.

Authors:  Sonja C J H Chua; Hui Qing Tan; David Engelberg; Lina H K Lim
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-30

Review 8.  The evolution and future of influenza pandemic preparedness.

Authors:  Walter N Harrington; Christina M Kackos; Richard J Webby
Journal:  Exp Mol Med       Date:  2021-05-06       Impact factor: 8.718

Review 9.  Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses.

Authors:  Reina Yamaji; Magdi D Saad; Charles T Davis; David E Swayne; Dayan Wang; Frank Y K Wong; John W McCauley; J S Malik Peiris; Richard J Webby; Ron A M Fouchier; Yoshihiro Kawaoka; Wenqing Zhang
Journal:  Rev Med Virol       Date:  2020-03-05       Impact factor: 11.043

10.  Characterization of highly pathogenic avian influenza H5Nx viruses in the ferret model.

Authors:  Joanna A Pulit-Penaloza; Nicole Brock; Claudia Pappas; Xiangjie Sun; Jessica A Belser; Hui Zeng; Terrence M Tumpey; Taronna R Maines
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.